Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic adipose derived mesenchymal stem cell (2 trials)
autologous endothelial progenitor cells (1 trial)
autologous human cord blood derived stem cells (1 trial)
autologous mesenchymal stem cells (1 trial)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Infarction (Phase 2)
Infarction, Middle Cerebral Artery (Phase 2)
Stroke (Phase 2)
Trials (3 total)
Trial APIs (4 total)